Imagene.me
AI genome interpretation · Consumer & clinical genomics
Overview
AI platform translating whole-genome data into health and disease-risk insights for consumers and clinicians.
What they do
Imagene.me is a Polish personalised-genomics company that uses artificial intelligence to translate whole-genome sequencing data into actionable health and disease-risk insights. It serves both consumers and clinicians, and offers partners in the health and prevention sectors tools to embed genomic analysis into their own products and services.
Lead program & status
The company's core platform pairs an expert-curated knowledge base with AI to generate personalised health predictions and recommendations, with an ambition to build an AI-driven health assistant supporting patients and medical professionals in real time. As of late 2024, Imagene.me raised investment from ABAN.VC and the NCBR Investment Fund to fund international expansion and scale its own products while supporting B2B partners adopting genomic solutions. Its stated mission is to become a leader in genomics-based preventive healthcare.
Why it matters
Whole-genome data is vast and hard to interpret. By automating that interpretation, Imagene.me aims to make genome-guided prevention practical at scale rather than confined to specialist clinics, positioning Poland in the growing consumer and clinical genomics market.
FAQ
- What does Imagene.me do with genome data?
- It uses AI to interpret whole-genome sequencing data and turn it into personalised health and disease-risk insights for consumers and clinicians.
- Who has invested in Imagene.me?
- In late 2024 it secured investment from ABAN.VC and the NCBR Investment Fund to support international expansion.
- Is Imagene.me only for consumers?
- No. It serves consumers and clinicians and also provides B2B tools so health and prevention partners can integrate genomic analysis.
Technology
Imagene.me works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.
Read the AI-Driven Drug Discovery brief →Related companies
Company website / source ↗ Open the interactive map →
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.